Described herein are pharmaceutical packaging programs which stop oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-delicate prescription drugs, such devices including a syringe by having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with extremely lower permeability to oxygen a